Latest Drug lupus disease in the next 50 years was assessed by the medical community to pave the way for the development of other drugs that more effectively treat diseases such immune system disorders.
Benlysta is the type of injectable drug designed to relieve flare-ups and pain caused by lupus, a disease that attacks the immune system and potentially fatal condition in which immunity can invade tissues and organs.
Human Genome Sciences Inc. The company took about 15 years to develop Benlysta. The plan, these drugs will be made and marketed with GlaxoSmithKline PLC.
The company also estimates that at least 200,000 people with lupus in the U.S. will benefit from this drug. However, experts stressed that Benlysta is not a miracle drug that will give.
This new drug tested against 35 per cent of patients in North America and will not be effective for patients who are already in very bad condition. In addition, this drug also did not show positive results in patients were black or African American, more precisely with this disease.
The FDA said in its official statement that this drug manufacturers must conduct advanced research exclusively to black patients.
Dr. Betty Diamond, who has been researching lupus for 30 years, assess the presence Benlysta will give researchers and developers passion for medicine.
"This will give the message that the conduct of successful clinical trials in lupus patients is possible and very important for the pharmaceutical industry to remain interested in this disease," said Diamond of the Feinstein Institute in New York.
Anda sedang membaca artikel tentang
FDA Approved Drugs New Lupus
Dengan url
http://lupuseritematosussistemik.blogspot.com/2011/03/fda-approved-drugs-new-lupus.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
FDA Approved Drugs New Lupus
namun jangan lupa untuk meletakkan link
sebagai sumbernya
0 komentar:
Posting Komentar